Immatics Biotechnologies Gmbh Stock Analysis

Immatics Stock Analysis Notes

The company had not issued any dividends in recent years. To learn more about immatics biotechnologies GmbH call the company at 49 7071 5397 0 or check out https://www.immatics.com.

Immatics Biotechnologies Investment Alerts

Immatics Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 673 M.

Immatics Profitablity

The company has Profit Margin (PM) of (1.04) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.42) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.42.

Management Efficiency

Immatics Biotechnologies has return on total asset (ROA) of (0.1217) % which means that it has lost $0.1217 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2432) %, meaning that it generated substantial loss on money invested by shareholders. Immatics Biotechnologies' management efficiency ratios could be used to measure how well Immatics Biotechnologies manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.2 in 2024. Return On Capital Employed is likely to drop to -0.3 in 2024. At this time, Immatics Biotechnologies' Other Current Assets are fairly stable compared to the past year. Asset Turnover is likely to climb to 0.14 in 2024, whereas Total Assets are likely to drop slightly above 325.9 M in 2024.

Technical Drivers

As of the 1st of December, Immatics Biotechnologies retains the Standard Deviation of 10.57, market risk adjusted performance of (0.78), and Risk Adjusted Performance of (0.12). Immatics Biotechnologies technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Immatics Biotechnologies variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and skewness to decide if Immatics Biotechnologies is priced fairly, providing market reflects its last-minute price of 0.5 per share. As Immatics Biotechnologies is a penny stock we also advise to confirm its jensen alpha numbers.

Immatics Biotechnologies Price Movement Analysis

Immatics Biotechnologies Predictive Daily Indicators

Immatics Biotechnologies Forecast Models

Immatics Biotechnologies' time-series forecasting models are one of many Immatics Biotechnologies' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Immatics Biotechnologies' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Immatics Biotechnologies prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Immatics shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Immatics Biotechnologies. By using and applying Immatics Stock analysis, traders can create a robust methodology for identifying Immatics entry and exit points for their positions.

When running Immatics Biotechnologies' price analysis, check to measure Immatics Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics Biotechnologies is operating at the current time. Most of Immatics Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Immatics Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immatics Biotechnologies' price. Additionally, you may evaluate how the addition of Immatics Biotechnologies to your portfolios can decrease your overall portfolio volatility.